Tomi Jun

Tomi Jun

Icahn School of Medicine at Mount Sinai

H-index: 19

North America-United States

Contact Tomi Jun

About Tomi Jun

Tomi Jun, With an exceptional h-index of 19 and a recent h-index of 19 (since 2020), a distinguished researcher at Icahn School of Medicine at Mount Sinai, specializes in the field of Cancer genomics, Cancer Immunology, Targeted Oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial

Corrections & amendments

Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial

Inherited cancer predisposing mutations in patients with therapy‐related myeloid neoplasms

Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma

Comprehensive molecular profiling and deep clinical annotation of electronic health records in patients with cancer: Implementation of the Avera/Sema4 oncology and analytics …

Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation

Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumors

Tomi Jun Information

University	Icahn School of Medicine at Mount Sinai
Position	Oncology Fellow
Citations(all)	1213
Citations(since 2020)	1192
Cited By	251
hIndex(all)	19
hIndex(since 2020)	19
i10Index(all)	31
i10Index(since 2020)	30
Email	Access Email
University Profile Page	Icahn School of Medicine at Mount Sinai
Google Scholar	View Google Scholar Profile

Tomi Jun Skills & Research Interests

Cancer genomics

Cancer Immunology

Targeted Oncology

Top articles of Tomi Jun

Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial

Nature Medicine

2024/1/19

Sara Lewis

H-Index: 25

Ronac Mamtani

H-Index: 27

Tomi Jun

H-Index: 10

Hui Xie

H-Index: 4

Kai Nie

H-Index: 13

Amir Horowitz

H-Index: 21

Li Wang

H-Index: 0

Menggang Yu

H-Index: 32

Jun Zhu

H-Index: 2

Corrections & amendments

2023

Lei Yu

H-Index: 3

Michael Matschiner

H-Index: 20

Mathieu Cusson

H-Index: 16

Marlene Jahnke

H-Index: 10

Claudia Kruschel

H-Index: 11

Masahiro Nakaoka

H-Index: 20

Francesca Rossi

H-Index: 1

Tal Dagan

H-Index: 28

Yves Van De Peer

H-Index: 78

Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial

Nature Medicine

2024/1

Se Hyun Kim

H-Index: 31

Jia Luo

H-Index: 32

Zhen Shi

H-Index: 6

Julie Chang

H-Index: 18

Tomi Jun

H-Index: 10

Sae-Won Han

H-Index: 37

Inherited cancer predisposing mutations in patients with therapy‐related myeloid neoplasms

British Journal of Haematology

2023/2

Tomi Jun

H-Index: 10

Lei Huang

H-Index: 4

Aaron Elliott

H-Index: 3

Friedrich Stölzel

H-Index: 24

James M Allan

H-Index: 30

Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma

World journal of gastrointestinal oncology

2023/11/11

Sirish Dharmapuri

H-Index: 6

Tomi Jun

H-Index: 10

Yi-Hsiang Huang

H-Index: 34

Uqba Khan

H-Index: 7

Anjana Pillai

H-Index: 17

Alessio Cortellini

H-Index: 17

David James Pinato

H-Index: 26

Comprehensive molecular profiling and deep clinical annotation of electronic health records in patients with cancer: Implementation of the Avera/Sema4 oncology and analytics …

Gynecologic Oncology

2023/9/1

Tomi Jun

H-Index: 10

John Lee

H-Index: 6

Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation

New England Journal of Medicine

2023/8/24

Sae-Won Han

H-Index: 37

Jong-Seok Lee

H-Index: 14

Zhen Shi

H-Index: 6

Julie Chang

H-Index: 18

Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumors

Journal of Cancer Research and Clinical Oncology

2023/7

Himanshu Joshi

H-Index: 9

Qian Qin

H-Index: 5

Bo Wang

H-Index: 9

Anish Parikh

H-Index: 4

Tomi Jun

H-Index: 10

Philip Garcia

H-Index: 26

Amanda Leiter

H-Index: 10

Detecting Ground Glass Opacity Features in Patients With Lung Cancer: Automated Extraction and Longitudinal Analysis via Deep Learning–Based Natural Language Processing

JMIR AI

2023/6/1

Tomi Jun

H-Index: 10

Meng Ma

H-Index: 11

Minghao Li

H-Index: 3

Tongyu Wang

H-Index: 1

Qi Pan

H-Index: 5

Eric Schadt

H-Index: 98

Xiaoyan Wang

H-Index: 3

Using EGFR amplification to stratify recurrent glioblastoma treated with immune checkpoint inhibitors

Cancer Immunology, Immunotherapy

2023/6

Tomi Jun

H-Index: 10

Kuan-Lin Huang

H-Index: 17

Analysis of real-world data to investigate evolving treatment sequencing patterns in advanced non-small cell lung cancers and their impact on survival

Journal of Thoracic Disease

2023/5/5

Mingwei Zhang

H-Index: 3

Minghao Li

H-Index: 3

Tomi Jun

H-Index: 10

Qi Pan

H-Index: 5

Eric Schadt

H-Index: 98

Xiaoyan Wang

H-Index: 3

Biomarker Development Trial of Satraplatin in Patients with Metastatic Castration-Resistant Prostate Cancer

The Oncologist

2023/4/1

Tomi Jun

H-Index: 10

Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study

Liver International

2023/3

Tomi Jun

H-Index: 10

Sirish Dharmapuri

H-Index: 6

Anjana Pillai

H-Index: 17

Uqba Khan

H-Index: 7

Alessio Cortellini

H-Index: 17

Co-primary endpoint analysis of HCRN GU 16-257: Phase 2 trial of gemcitabine, cisplatin, plus nivolumab with selective bladder sparing in patients with muscle-invasive bladder …

2023/2/20

Ronac Mamtani

H-Index: 27

Menggang Yu

H-Index: 32

Tomi Jun

H-Index: 10

Clinical utility of widespread germline testing of cancer patients in a diverse community cancer clinic.

2022/6/1

Tomi Jun

H-Index: 10

Dhwani Mehta

H-Index: 4

QOPI Clinical Informatics: A digital platform to enable real-time quality reporting, clinical decision support, and rapid learning.

2022/6/1

Kubra Karagoz

H-Index: 11

Eric Schadt

H-Index: 98

Tomi Jun

H-Index: 10

Xiaoyan Wang

H-Index: 3

Rong Chen

H-Index: 21

Xiang Zhou

H-Index: 10

Prevalence of Pathogenic Germline Mutations in Solid Tumor Predisposition Genes Detected By Tumor-Normal Whole Exome Sequencing Analysis Among Adults with Hematologic Malignancies

Blood

2022/11/15

Tomi Jun

H-Index: 10

Treatment Profile of CAR-T Cell Therapy Induced Cytokine Release Syndrome and Neurotoxicity: Insights from Real-World Evidence

Blood

2022/11/15

Lan Jin

H-Index: 2

Minghao Li

H-Index: 3

Tomi Jun

H-Index: 10

Qi Pan

H-Index: 5

Eric Schadt

H-Index: 98

Xiaoyan Wang

H-Index: 3

Phase II Clinical and Translational Study of Everolimus±Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial Carcinoma

The oncologist

2022/6/1

Tomi Jun

H-Index: 10

Mark Fleming

H-Index: 17

Huan Wang

H-Index: 4

Inpatient administration of alpha-1-adrenergic receptor blocking agents reduces mortality in male COVID-19 patients

Frontiers in Medicine

2022/2/28

Tomi Jun

H-Index: 10

Zichen Wang

H-Index: 0

Maximilian F Konig

H-Index: 13

Chetan Bettegowda

H-Index: 39

Rong Chen

H-Index: 21

Li Li

H-Index: 15

See List of Professors in Tomi Jun University(Icahn School of Medicine at Mount Sinai)

academic-engine

Useful Links

List of top 50 universities

List of top 100 universities

List of top 500 universities

Find Professors Email

Find Universities Email

CUFinder Academic Engine